JAMA Pediatrics

Presented today at :

Meta-analysis: In youth, device-measured of moderate and vigorous intensity was associated with a more favorable later cardiometabolic profile, including lower insulin, low-density lipoprotein cholesterol, and triglyceride levels.

The associations were weak, were not observed for body mass index, and varied by age, body mass index, follow-up time, and modeling approach.

https://ja.ma/4j8kpSW

International Society for Physical Activity & Health (ISPAH)

Among US parents, awareness of , also referred to as 530A accounts, was lower among those with lower household income, fewer assets, and other markers of lower socioeconomic advantage.

These findings indicate that an opt-in early-life wealth policy may be less likely to reach children in families with fewer resources and could widen wealth gaps from birth.

https://ja.ma/4rUqwwu

Among children presenting to the , the Epic pediatric early detection alert identified only a minority of patients who met the Phoenix Sepsis Score criteria for sepsis in the first 24 hours after arrival.

The alert also identified only a minority of cases before sepsis onset, indicating limited utility for timely pediatric sepsis screening.

https://ja.ma/4hFHSZ1

💬 Viewpoint: Injuries related to devices in youth are increasing, with reports indicating more severe injury patterns than with conventional pedal bicycles and low helmet use among injured riders.

Current laws on age, helmet use, speed limits, and place of riding vary widely and are rarely enforced, with implications for state and local injury prevention policy.

https://ja.ma/4dZeJHh

📢 JAMA+ Trials wants to hear from you.

Share your perspective in our latest poll and help spark discussion around the future of clinical trial research.

📊 Vote now: https://ja.ma/4hNVmTU

📢 Share your opinion: How many clinical trials that claim to be "pragmatic" actually provide useful evidence for real-world decision-making?

Vote now and join the discussion: https://ja.ma/4h5U1rm

📣 Follow JAMA+ Trials to get curated access to the best of the JAMA Network’s trial research, commentaries, and educational resources. Learn more and subscribe to the newsletter: https://ja.ma/4hrMK46

💭 In your opinion, how many clinical trials that claim to be "pragmatic" are successful in providing useful evidence for real-world decision-making?

JAMA+ Trials wants to hear from you. Share your perspective in our latest poll and help spark discussion around the future of clinical trial research.

🔗 Vote now: https://ja.ma/4h3rH8Z

📢 Share your opinion: New JAMA+ Trials Poll!

How many clinical trials that claim to be "pragmatic" actually provide useful evidence for real-world decision-making?

📊 Vote now and join the discussion: https://ja.ma/3UYCiJP



🔗 JAMA+ Trials highlights the implications and innovations of clinical trial research from across the JAMA Network to advance evidence-based medicine and public health.

📬 Learn more and subscribe to the newsletter: https://ja.ma/4xD4TBQ

📣 Tomorrow, JAMA and JAMA Network Editor in Chief Kirsten Bibbins-Domingo, MD, PhD, MAS will join leaders from public health, academia, and city resilience at Yale University Climate Week NYC for Resilient Cities, Reimagining Health.

📅 September 22, 2026
🕘 9:00-10:30 a.m. ET

➡️ Learn more: https://ja.ma/4cWqIoA

💬 Editorial: Maternal infections in pregnancy were associated with intellectual disability and , with accounting for roughly half of identified cases in the related study.

These findings indicate that congenital infection remains a relevant prenatal factor in neurodevelopmental outcomes and may inform public health, vaccine development, and prevention strategies.

https://ja.ma/3TfKZi8